Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
about
No longer falling on deaf ears: mechanisms of degeneration and regeneration of cochlear ribbon synapses.Magnetic Beads Enhance Adhesion of NIH 3T3 Fibroblasts: A Proof-of-Principle In Vitro Study for Implant-Mediated Long-Term Drug Delivery to the Inner EarImproved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened CochleaEnhanced auditory neuron survival following cell-based BDNF treatment in the deaf guinea pig.Neurotrophic effects of GM1 ganglioside and electrical stimulation on cochlear spiral ganglion neurons in cats deafened as neonatesEffect of hyperbaric oxygen on BDNF-release and neuroprotection: Investigations with human mesenchymal stem cells and genetically modified NIH3T3 fibroblasts as putative cell therapeutics.Firing frequency and entrainment maintained in primary auditory neurons in the presence of combined BDNF and NT3.Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies.Targeted delivery of brain-derived neurotrophic factor for the treatment of blindness and deafness.Effect of monopolar and bipolar electric stimulation on survival and size of human spiral ganglion cells as studied by postmortem histopathology.Effects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats.Phosphodiesterase type 4 inhibitor rolipram improves survival of spiral ganglion neurons in vitro7,8,3'-Trihydroxyflavone, a potent small molecule TrkB receptor agonist, protects spiral ganglion neurons from degeneration both in vitro and in vivoPolypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons.Brain-derived neurotrophic factor modulates auditory function in the hearing cochlea.Spiral ganglion neuron survival and function in the deafened cochlea following chronic neurotrophic treatment.Combining cell-based therapies and neural prostheses to promote neural survivalThe spiral ganglion: connecting the peripheral and central auditory systems.Brain-derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats.Lipidic nanocapsule drug delivery: neuronal protection for cochlear implant optimizationLocalized cell and drug delivery for auditory prostheses.Surgical access to the mammalian cochlea for cell-based therapiesStem cell transplantation for auditory nerve replacementFactors influencing neurotrophic effects of electrical stimulation in the deafened developing auditory system.Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss.Neurotrophic factors and neural prostheses: potential clinical applications based upon findings in the auditory system.Aminoglycoside-induced degeneration of adult spiral ganglion neurons involves differential modulation of tyrosine kinase B and p75 neurotrophin receptor signaling.Clinical application of neurotrophic factors: the potential for primary auditory neuron protectionCochlear implantation in rats: a new surgical approach.An in vitro model of developmental synaptogenesis using cocultures of human neural progenitors and cochlear explantsBrain derived neurotrophic factor and neurotrophic factor 3 modulate neurotransmitter receptor expressions on developing spiral ganglion neurons.Bone morphogenetic protein 4 promotes the survival and preserves the structure of flow-sorted Bhlhb5+ cochlear spiral ganglion neurons in vitroDrug delivery to the inner ear.The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protectionFate of embryonic stem cells transplanted into the deafened mammalian cochlea.Auditory hair cell explant co-cultures promote the differentiation of stem cells into bipolar neurons.Neurotrophic support and oxidative stress: converging effects in the normal and diseased nervous system.The Trk A, B, C's of neurotrophins in the cochlea.Nanomedicine strategies for drug delivery to the ear.From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)
P2860
Q28088712-D273CBFD-251E-4E5C-9F71-C288CFD753D3Q28550399-D2F67BC9-ABAB-4499-B10A-5A6AA3C7D0EFQ28553035-7A25EE91-5429-4FF6-9A31-7CFC4F27CC7BQ28740987-DFF5C070-8113-42EB-9206-B37D971E6DF2Q28754351-E2898E0D-A2F6-49BC-8396-8D0B6050CD2FQ30354806-20E290F4-2BA6-4B9F-A65E-89B4E7820866Q30380811-A8FED370-E156-4F24-A5FE-30B1461F938EQ30409983-04271FB8-63CE-4FC4-8B9E-DEF574573FB8Q30411312-650FADA5-30AA-4DBD-820D-AE35D8C4CC41Q30433607-A30BE542-DB70-4626-91F6-DE2C11CFCCDEQ30440839-16024F97-7855-4299-B919-241F4BFB323FQ30441402-E5AD5604-7BE0-456A-B100-85AE694685C6Q30453707-3566683D-E45A-4BA1-9D54-C3BF8CDE1917Q30458466-70C288EA-3056-405B-BA8B-6EF18BAE199EQ30458638-E301C04C-A845-47E9-BCEF-A740D4DEB260Q30460283-EADB63C3-F488-459A-8564-26296F8E54C4Q30463130-223FD6FA-34EB-466A-8BAC-233CEAFFA98EQ30465163-5963636B-B8CE-454B-B58C-185C8801605EQ30467124-A7A30038-C5EC-40F8-8044-86DD29CD8A0AQ30467283-F4A07811-24FF-4234-884F-C171FDED1639Q30475885-92CA56D2-2CB5-4E84-8283-4267ED59D68BQ30484887-7AF16471-6C59-4A6B-AE33-2D479CDE56A6Q30487720-05F42799-9D15-448B-A479-45A76DAC47FCQ30487722-F804EF45-90B3-42CD-B43E-B935BF2ED650Q30487728-4277A4C2-5A35-41A1-ABF6-B06A1D23665EQ30498580-259E24BF-AC3D-4422-B083-FE305AB4B662Q30499378-483AAE18-D292-4875-A682-8B8F124E5221Q30499419-9B72D2F6-ECF4-424B-99BE-779D0AE98839Q30499423-291A694F-CB83-49E5-A451-931C3326ABDDQ30541094-D9A66D29-9A4A-4F2E-A464-61FAC053AA71Q33568185-D6459DF0-7E68-4832-BCBB-F8C022BDC48FQ33799313-3CA94C8F-9760-4B72-9810-38DF31147FD7Q34466002-FACABD8B-E5DD-44BB-92CC-0D578AFFD575Q35154333-C55938D7-9EBC-4609-AB6C-2EAF29FD7D2FQ35663311-52657B16-F157-4D20-A47D-E4EA7D4E7E67Q35676470-C083888C-4B6F-490F-ADED-BE6F1D2C1B17Q37393553-37409BD9-23BB-4CFE-984D-0C053957373DQ38050349-410925A2-CB9C-4C01-83F1-CC02025540D4Q38120319-517C1A87-97F8-4FB0-A6B6-E0E4D12C6580Q38168376-D9ADF18C-C8A7-47F7-97C4-E126643F45B4
P2860
Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
@ast
Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
@en
type
label
Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
@ast
Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
@en
prefLabel
Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
@ast
Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
@en
P2860
P1476
Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
@en
P2093
Robert K Shepherd
Sarah L McGuinness
P2860
P304
P356
10.1097/01.MAO.0000185063.20081.50
P577
2005-09-01T00:00:00Z